搜索临床试验以:OTX-TKI
总计2940个结果
-
Tongji HospitalWuhan University; Hubei Cancer Hospital; Wuhan Union Hospital, China; Renmin Hospital of Wuhan University完全的
-
Spanish Lung Cancer Group完全的
-
Cancer Institute and Hospital, Chinese Academy...未知非小细胞肺癌 | III 期非小细胞肺癌 | EGFR突变相关肿瘤
-
Oui Therapeutics, Inc.National Institute of Mental Health (NIMH)邀请报名
-
Tata Memorial Hospital招聘中
-
Turino, Gerard, M.D.National Heart, Lung, and Blood Institute (NHLBI)完全的
-
European LeukemiaNetLudwig-Maximilians - University of Munich; Heidelberg University主动,不招人
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdSunshine Lake Pharma Co., Ltd.终止
-
Ahon Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences未知
-
Shanghai Pulmonary Hospital, Shanghai, China未知非小细胞肺癌 | 表皮生长因子受体基因突变
-
Ocular Therapeutix, Inc.Duke University; Fortrea招聘中
-
Medical College of WisconsinMemorial Sloan Kettering Cancer Center; Dana-Farber Cancer Institute; University of Chicago; Emory... 和其他合作者完全的
-
Poitiers University Hospital招聘中
-
Yue HanJiangsu HengRui Medicine Co., Ltd.招聘中
-
Selayang Hospital完全的
-
The University of Tennessee, KnoxvilleSmith & Nephew, Inc.完全的
-
Centro Nacional de Investigaciones Oncologicas...M.D. Anderson Cancer Center; Hospital Universitari de Bellvitge; Hospital Universitario de Fuenlabrada终止
-
University of Illinois at Chicago完全的
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML Consortium招聘中
-
Federal University of São PauloInstituto Paulista de Estudos e Pesquisa em Oftalmologia; Eye Clinic Day Hospital, São Paulo完全的
-
Arbutus Biopharma Corporation完全的
-
University of LiegeKU Leuven; Maastricht University Medical Center完全的
-
The University of Tennessee, KnoxvilleMicroPort Orthopedics Inc.尚未招聘
-
The University of Tennessee, KnoxvilleStryker Orthopaedics完全的
-
Arbutus Biopharma CorporationUnited States Department of Defense终止
-
The Fourth Affiliated Hospital of Zhejiang University...完全的
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国